Ladenburg Thalmann Financial Services’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | $0 | Sell |
89
-7
| -7% | – | ﹤0.01% | 5547 |
|
|
2019
Q3 | $7K | Hold |
96
| – | – | ﹤0.01% | 4563 |
|
|
2019
Q2 | $8K | Hold |
96
| – | – | ﹤0.01% | 4555 |
|
|
2019
Q1 | $10K | Hold |
96
| – | – | ﹤0.01% | 4384 |
|
|
2018
Q4 | $8K | Hold |
96
| – | – | ﹤0.01% | 4414 |
|
|
2018
Q3 | $9K | Sell |
96
-59
| -38% | -$5.53K | ﹤0.01% | 4355 |
|
|
2018
Q2 | $15K | Hold |
155
| – | – | ﹤0.01% | 4016 |
|
|
2018
Q1 | $15K | Sell |
155
-14
| -8% | -$1.36K | ﹤0.01% | 4016 |
|
|
2017
Q4 | $18K | Sell |
169
-49
| -22% | -$5.22K | ﹤0.01% | 3867 |
|
|
2017
Q3 | $25K | Sell |
218
-137
| -39% | -$15.7K | ﹤0.01% | 3563 |
|
|
2017
Q2 | $40K | Sell |
355
-204
| -36% | -$23K | ﹤0.01% | 3179 |
|
|
2017
Q1 | $65K | Sell |
559
-274
| -33% | -$31.9K | ﹤0.01% | 2704 |
|
|
2016
Q4 | $88K | Buy |
833
+632
| +314% | +$66.8K | ﹤0.01% | 2424 |
|
|
2016
Q3 | $23K | Sell |
201
-50
| -20% | -$5.72K | ﹤0.01% | 3317 |
|
|
2016
Q2 | $37K | Sell |
251
-190
| -43% | -$28K | ﹤0.01% | 2922 |
|
|
2016
Q1 | $63K | Hold |
441
| – | – | ﹤0.01% | 2419 |
|
|
2015
Q4 | $68K | Buy |
441
+100
| +29% | +$15.4K | ﹤0.01% | 2343 |
|
|
2015
Q3 | $49K | Buy |
341
+83
| +32% | +$11.9K | ﹤0.01% | 2487 |
|
|
2015
Q2 | $37K | Buy |
258
+162
| +169% | +$23.2K | ﹤0.01% | 2803 |
|
|
2015
Q1 | $14K | Sell |
96
-158
| -62% | -$23K | ﹤0.01% | 3425 |
|
|
2014
Q4 | $37K | Buy |
254
+117
| +85% | +$17K | ﹤0.01% | 2553 |
|
|
2014
Q3 | $21K | Buy |
+137
| New | +$21K | ﹤0.01% | 2643 |
|